These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 8148757)
1. [The influence of n-acetylcysteine on chemiluminescence of granulocytes in peripheral blood of patients with chronic bronchitis]. Jankowska R; Passowicz-Muszyńska E; Medrala W; Banaś T; Marcinkowska A Pneumonol Alergol Pol; 1993; 61(11-12):586-91. PubMed ID: 8148757 [TBL] [Abstract][Full Text] [Related]
2. [The influence of vitamin A on production of oxygen free radicals and activity of granulocyte catalase in patients with chronic bronchitis]. Jankowska R; Passowicz-Muszyńska E; Banaś T; Marcinkowska A; Medrala W Pneumonol Alergol Pol; 1994; 62(11-12):628-33. PubMed ID: 7719263 [TBL] [Abstract][Full Text] [Related]
3. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease. Kasielski M; Nowak D Respir Med; 2001 Jun; 95(6):448-56. PubMed ID: 11421501 [TBL] [Abstract][Full Text] [Related]
4. [Antioxidant treatment with N-acetylcysteine and vitamin C in patients with chronic bronchitis]. Lukas R; Schärling B; Schultze-Werninghaus G; Gillissen A Dtsch Med Wochenschr; 2005 Mar; 130(11):563-7. PubMed ID: 15761783 [TBL] [Abstract][Full Text] [Related]
5. Oxidant-antioxidant balance in granulocytes during ARDS. Effect of N-acetylcysteine. Laurent T; Markert M; Feihl F; Schaller MD; Perret C Chest; 1996 Jan; 109(1):163-6. PubMed ID: 8549180 [TBL] [Abstract][Full Text] [Related]
6. [N-acetylcysteine: a functional oxygen radical scavenger in vitro and ex vivo in monocytes and neutrophilic granulocytes of patients with COPD]. Jaworska M; Gillissen A; Schärling B; Wickenburg D; Schultze-Werninghaus G Pneumologie; 1995 Oct; 49(10):539-45. PubMed ID: 8584524 [TBL] [Abstract][Full Text] [Related]
7. [Steroid response after long-term treatment with oral N-acetylcysteine in patients with chronic obstructive bronchitis]. Evald T; Hansen M; Balsløv S; Brorson-Riis L; Hansen NC; Maltbaek N; Thorshauge H Ugeskr Laeger; 1989 Nov; 151(46):2076-8. PubMed ID: 2688231 [TBL] [Abstract][Full Text] [Related]
8. Fluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitis. Schermer T; Chavannes N; Dekhuijzen R; Wouters E; Muris J; Akkermans R; van Schayck O; van Weel C Respir Med; 2009 Apr; 103(4):542-51. PubMed ID: 19138505 [TBL] [Abstract][Full Text] [Related]
9. Oral N-acetylcysteine attenuates pulmonary emphysema and alveolar septal cell apoptosis in smoking-induced COPD in rats. Cai S; Chen P; Zhang C; Chen JB; Wu J Respirology; 2009 Apr; 14(3):354-9. PubMed ID: 19341424 [TBL] [Abstract][Full Text] [Related]
10. [N-Acetylcysteine: low and high doses in the treatment of chronic obstructive lung diseases in Chernobyl accident liquidators]. Chikina SIu; Iagmurov BKh; Kopylev ID; Soodaeva SK; Chuchalin AG Ter Arkh; 2002; 74(3):62-5. PubMed ID: 11980127 [TBL] [Abstract][Full Text] [Related]
11. Neutrophil activation in severe, early-onset COPD patients versus healthy non-smoker subjects in vitro: effects of antioxidant therapy. Milara J; Juan G; Peiró T; Serrano A; Cortijo J Respiration; 2012; 83(2):147-58. PubMed ID: 22094549 [TBL] [Abstract][Full Text] [Related]
12. Effects of inhaled N-acetylcysteine in combination with terbutaline. Stiksa G; Nemcek K; Melin S Eur J Respir Dis; 1984 May; 65(4):278-82. PubMed ID: 6723838 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials. Grandjean EM; Berthet P; Ruffmann R; Leuenberger P Clin Ther; 2000 Feb; 22(2):209-21. PubMed ID: 10743980 [TBL] [Abstract][Full Text] [Related]
14. Human neutrophil oxidative bursts and their in vitro modulation by different N-acetylcysteine concentrations. Allegra L; Dal Sasso M; Bovio C; Massoni C; Fonti E; Braga PC Arzneimittelforschung; 2002; 52(9):669-76. PubMed ID: 12404881 [TBL] [Abstract][Full Text] [Related]
15. Protective effects of N-acetylcysteine on the peroxidative changes of rat lungs exposed to inhalation of thinners. Dillioglugil MO; Ilgazli A; Maral H; Sengul C; Ozdemir G; Ercin C Respirology; 2005 Nov; 10(5):615-9. PubMed ID: 16268915 [TBL] [Abstract][Full Text] [Related]
16. New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine. van Overveld FJ; Demkow U; Górecka D; de Backer WA; Zielinski J J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():135-42. PubMed ID: 16204787 [TBL] [Abstract][Full Text] [Related]
17. [Therapy of respiratory tract diseases with N-acetylcysteine. An open therapeutic observation study of 2,512 patients]. Völkl KP; Schneider B Fortschr Med; 1992 Jun; 110(18):346-50. PubMed ID: 1644396 [TBL] [Abstract][Full Text] [Related]
18. [N-acetylcystein in the therapy of chronic bronchitis]. Reichenberger F; Tamm M Pneumologie; 2002 Dec; 56(12):793-7. PubMed ID: 12486618 [TBL] [Abstract][Full Text] [Related]
19. Oral doxophylline in patients with chronic obstructive pulmonary disease. Villani F; De Maria P; Ronchi E; Galimberti M Int J Clin Pharmacol Ther; 1997 Mar; 35(3):107-11. PubMed ID: 9088999 [TBL] [Abstract][Full Text] [Related]
20. [A clinical study of N-acetylcysteine treatment in chronic hepatitis B patients]. Wang N; Shi XF; Guo SH; Zhang DZ; Ren H Zhonghua Gan Zang Bing Za Zhi; 2008 Jul; 16(7):487-9. PubMed ID: 18647523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]